171 related articles for article (PubMed ID: 3200827)
1. Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.
Gaynor RB; Kuwabara MD; Wu FK; Garcia JA; Harrich D; Briskin M; Wall R; Sigman DS
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9406-10. PubMed ID: 3200827
[TBL] [Abstract][Full Text] [Related]
2. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
Maciaszek JW; Talmage DA; Viglianti GA
J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
Twu JS; Chu K; Robinson WS
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
[TBL] [Abstract][Full Text] [Related]
5. Alterations in binding characteristics of the human immunodeficiency virus enhancer factor.
Wu F; Garcia J; Mitsuyasu R; Gaynor R
J Virol; 1988 Jan; 62(1):218-25. PubMed ID: 3257103
[TBL] [Abstract][Full Text] [Related]
6. Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat.
Harrich D; Garcia J; Wu F; Mitsuyasu R; Gonazalez J; Gaynor R
J Virol; 1989 Jun; 63(6):2585-91. PubMed ID: 2657100
[TBL] [Abstract][Full Text] [Related]
7. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
Verhoef K; Sanders RW; Fontaine V; Kitajima S; Berkhout B
J Virol; 1999 Feb; 73(2):1331-40. PubMed ID: 9882338
[TBL] [Abstract][Full Text] [Related]
8. Differential DNA sequence specificity and regulation of HIV-1 enhancer activity by cRel-RelA transcription factor.
Hansen SK; Guerrini L; Blasi F
J Biol Chem; 1994 Sep; 269(35):22230-7. PubMed ID: 8071349
[TBL] [Abstract][Full Text] [Related]
9. The kappa B enhancer motifs in human immunodeficiency virus type 1 and simian virus 40 recognize different binding activities in human Jurkat and H9 T cells: evidence for NF-kappa B-independent activation of the kappa B motif.
Phares W; Franza BR; Herr W
J Virol; 1992 Dec; 66(12):7490-8. PubMed ID: 1331533
[TBL] [Abstract][Full Text] [Related]
10. Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.
Wu FK; Garcia JA; Harrich D; Gaynor RB
EMBO J; 1988 Jul; 7(7):2117-30. PubMed ID: 3138113
[TBL] [Abstract][Full Text] [Related]
11. Functional similarities between human immunodeficiency virus type 1 and simian virus 40 kappa B proto-enhancers.
Phares W; Herr W
J Virol; 1991 May; 65(5):2200-10. PubMed ID: 1850006
[TBL] [Abstract][Full Text] [Related]
12. A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1.
Giacca M; Gutierrez MI; Menzo S; d'Adda di Fagagna F; Falaschi A
Virology; 1992 Jan; 186(1):133-47. PubMed ID: 1727595
[TBL] [Abstract][Full Text] [Related]
13. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1.
Roebuck KA; Brenner DA; Kagnoff MF
J Clin Invest; 1993 Sep; 92(3):1336-48. PubMed ID: 8376588
[TBL] [Abstract][Full Text] [Related]
14. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element.
Speck NA; Renjifo B; Hopkins N
J Virol; 1990 Feb; 64(2):543-50. PubMed ID: 2104942
[TBL] [Abstract][Full Text] [Related]
15. Interaction of enhancer-binding protein EBP1 (NF-kappa B) with the human immunodeficiency virus type 1 enhancer.
Clark L; Matthews JR; Hay RT
J Virol; 1990 Mar; 64(3):1335-44. PubMed ID: 2406459
[TBL] [Abstract][Full Text] [Related]
16. Phorbol ester reduces constitutive nuclear NF kappa B and inhibits HIV-1 production in mature human monocytic cells.
Mufson RA; Myers C; Turpin JA; Meltzer M
J Leukoc Biol; 1992 Dec; 52(6):637-44. PubMed ID: 1464736
[TBL] [Abstract][Full Text] [Related]
17. Myb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR-mediated transcription.
Dasgupta P; Saikumar P; Reddy CD; Reddy EP
Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8090-4. PubMed ID: 2236022
[TBL] [Abstract][Full Text] [Related]
18. Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence.
Gimble JM; Duh E; Ostrove JM; Gendelman HE; Max EE; Rabson AB
J Virol; 1988 Nov; 62(11):4104-12. PubMed ID: 2845125
[TBL] [Abstract][Full Text] [Related]
19. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
Zachar V; Ebbesen P; Thomas RA; Zacharova V; Goustin AS
J Gen Virol; 1994 Jun; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
[TBL] [Abstract][Full Text] [Related]
20. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes.
Cross SL; Halden NF; Lenardo MJ; Leonard WJ
Science; 1989 Apr; 244(4903):466-9. PubMed ID: 2497520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
